Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
Danones GLP-1 strategy: summary Danone targets GLP-1 users with whey-rich yoghurt supporting muscle health Microbiome focused medical nutrition aims to rebalance gut impacted by treatment Kate Farms offers high protein plant based shakes supporting satiety and muscle health Consumer and medical approaches expand opportunities as GLP-1 demand grows Launch timing and markets depend on regulation alignment and patient needs As the early signs of GLP-1-driven disruption emerge in the food sector, more manufacturers are exploring weight management-friendly innovation
Body weight and BMI monthly for weight management
Glucose-dependent insulinotropic polypeptide: A bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans
